New drug SHR-2173 put to the test in healthy volunteers

This early-stage study is testing a single dose of a new drug called SHR-2173 in 18 healthy adults. The goal is to see how safe it is, how the body absorbs and breaks it down, and whether the immune system reacts to it. Participants will be randomly assigned to receive either the drug or a placebo, and no direct treatment benefit is expected.